Mereo BioPharma Group plc filed a Form 8-K at 13:10 UTC on Monday, 9 November 2026. On November 9, 2026, Mereo BioPharma Group plc announced its financial results for the third quarter ended September 30, 2026 and provided an update on recent corporate developments.
Form 8-K is the current report that U.S. public companies file with the SEC to disclose significant events between their regular reports. This filing reports Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits).
Source: U.S. Securities and Exchange Commission (EDGAR) filing